UK markets closed

NovoCure Limited (038.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
13.15+1.41 (+12.02%)
At close: 08:19AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 1.48B
Enterprise value 1.23B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.56
Price/book (mrq)3.77
Enterprise value/revenue 2.34
Enterprise value/EBITDA -7.74

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-81.18%
S&P500 52-week change 322.38%
52-week high 378.30
52-week low 310.08
50-day moving average 313.13
200-day moving average 315.21

Share statistics

Avg vol (3-month) 327
Avg vol (10-day) 3N/A
Shares outstanding 5107.61M
Implied shares outstanding 6112.77M
Float 898.02M
% held by insiders 19.26%
% held by institutions 182.40%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -36.67%
Operating margin (ttm)-28.51%

Management effectiveness

Return on assets (ttm)-11.18%
Return on equity (ttm)-48.70%

Income statement

Revenue (ttm)525.66M
Revenue per share (ttm)4.92
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)N/A
EBITDA -195.61M
Net income avi to common (ttm)-192.74M
Diluted EPS (ttm)-1.89
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)870.15M
Total cash per share (mrq)8.09
Total debt (mrq)595.26M
Total debt/equity (mrq)165.65%
Current ratio (mrq)6.26
Book value per share (mrq)3.34

Cash flow statement

Operating cash flow (ttm)-88.18M
Levered free cash flow (ttm)-28.4M